Bull
$92.49
Scenario price
$134.920
-9.647 (-7.15%)At close
Entegris, Inc. is a supplier of critical advanced materials and process solutions for semiconductors and other high-technology industries. Its segments include Materials Solutions (MS) and Advanced Purity Solutions (APS). The MS segment provides materials-based solutions, such as chemical vapor and atomic layer deposition materials, chemical mechanical planarization (CMP) slurries and pads, ion implantation specialty gases, formulated etch and clean materials, and other specialty materials. The APS segment offers filtration, purification and contamination-control solutions that improve customers’ yield and device reliability by ensuring the purity of critical liquid chemistries and gases and the cleanliness of wafers and other substrates used throughout semiconductor manufacturing processes, the semiconductor ecosystem and other high-technology industries. It has manufacturing, customer service and/or research facilities in the United States, Canada, China, Germany and others.
Entegris Inc is a good buy right now due to its current price of $134.92, which is significantly below the analyst price targets of $200 and $180. The company has shown strong growth with a year-to-date change of +50.65% and a recent earnings surprise of +12.05%, indicating robust operational performance. However, the RSI is at 32.965, suggesting it is oversold, which could present a buying opportunity. The main risk is the recent 5-day change of -6.08%, indicating potential short-term volatility.
Deutsche Bank
$200
2026-08-12
Deutsche Bank
2026-08-12
Price Target
$200
Deutsche Bank
$152
2026-08-05
Deutsche Bank
2026-08-05
Price Target
$152
Oppenheimer
$180
2026-08-05
Oppenheimer
2026-08-05
Price Target
$180
Freedom Capital
$140
2026-08-03
Freedom Capital
2026-08-03
Price Target
$140
Deutsche Bank
$155
2026-07-06
Deutsche Bank
2026-07-06
Price Target
$155
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Entegris to Host Investor Day in New York City

Markets Set for Positive Close Despite Tough Week

Entegris Upholds Key Patents in Taiwan and China

Bank of America Reiterates Buy on CoreWeave Following Strong Earnings

Entegris (ENTG) Q2 2026 Earnings Call Transcript
Entegris, Inc. is a supplier of critical advanced materials and process solutions for semiconductors and other high-technology industries. Its segments include Materials Solutions (MS) and Advanced Purity Solutions (APS). The MS segment provides materials-based solutions, such as chemical vapor and atomic layer deposition materials, chemical mechanical planarization (CMP) slurries and pads, ion implantation specialty gases, formulated etch and clean materials, and other specialty materials. The APS segment offers filtration, purification and contamination-control solutions that improve customers’ yield and device reliability by ensuring the purity of critical liquid chemistries and gases and the cleanliness of wafers and other substrates used throughout semiconductor manufacturing processes, the semiconductor ecosystem and other high-technology industries. It has manufacturing, customer service and/or research facilities in the United States, Canada, China, Germany and others. It operates in the Technology sector (PLASTICS PRODUCTS, NEC industry).
Entegris Inc is a good buy right now due to its current price of $134.92, which is significantly below the analyst price targets of $200 and $180. The company has shown strong growth with a year-to-date change of +50.65% and a recent earnings surprise of +12.05%, indicating robust operational performance. However, the RSI is at 32.965, suggesting it is oversold, which could present a buying opportunity. The main risk is the recent 5-day change of -6.08%, indicating potential short-term volatility.
9 analysts cover ENTG: 6 rate it Buy, 3 Hold and 0 Sell. The average price target is 123.14.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.